These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6245621)

  • 1. Herpes zoster-varicella in cutaneous T-cell lymphomas.
    Vonderheid EC; van Voorst Vader PC
    Arch Dermatol; 1980 Apr; 116(4):408-12. PubMed ID: 6245621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic herpes simplex infection in cutaneous T-cell lymphomas.
    Vonderheid EC; Milstein HJ; Thompson KD; Wu BC
    Arch Dermatol; 1980 Sep; 116(9):1018-22. PubMed ID: 6968178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.
    Cook BE; Bartley GB; Pittelkow MR
    Ophthalmology; 1999 Jul; 106(7):1339-44. PubMed ID: 10406618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
    J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal manifestations in cutaneous T-cell lymphomas.
    Brigham BA; Bunn PA; Horton JE; Schechter GP; Wahl LM; Bradley EC; Dunnick NR; Matthews MJ
    Arch Dermatol; 1982 Jul; 118(7):461-7. PubMed ID: 6979976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections complicating mycosis fungoides and Sézary syndrome.
    Axelrod PI; Lorber B; Vonderheid EC
    JAMA; 1992 Mar; 267(10):1354-8. PubMed ID: 1740857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
    Bunn PA; Fischmann AB; Schechter GP; Kumar PP; Ihde DC; Cohen MH; Fossieck BE; Gazdar AF; Matthews MJ; Eddy JL; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):713-7. PubMed ID: 109208
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage.
    Kerschmann RL; Berger TG; Weiss LM; Herndier BG; Abrahms KM; Heon V; Schulze K; Kaplan LD; Resnik SD; LeBoit PE
    Arch Dermatol; 1995 Nov; 131(11):1281-8. PubMed ID: 7503572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia.
    Kempf W; Kutzner H; Kettelhack N; Palmedo G; Burg G
    Br J Dermatol; 2005 Jun; 152(6):1327-31. PubMed ID: 15949002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of cutaneous T-cell lymphomas with arotinoid].
    Mahrle G; Thiele B; Ippen H
    Dtsch Med Wochenschr; 1983 Nov; 108(46):1753-7. PubMed ID: 6605844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated cutaneous herpes simplex infection in cutaneous T-cell lymphoma.
    Taulbee KS; Johnson SC
    Arch Dermatol; 1981 Feb; 117(2):114-5. PubMed ID: 6970545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.
    Cook BE; Bartley GB; Pittelkow MR
    Trans Am Ophthalmol Soc; 1998; 96():309-24; discussion 324-7. PubMed ID: 10360295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides: pathophysiology and emerging therapies.
    Duvic M; Foss FM
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S21-8. PubMed ID: 18086343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.